Sign in

or Register now

OsteoporosisConnection.com

See all of our health sites at www.HealthCentral.com
Sunday, November, 29, 2009
  • Font size
  • Bookmark
  • Save
  

Lila de Tantillo's SharePosts

Clothes for Osteoporosis Patients

Osteoporosis can impose a number of serious challenges - a fear of fracture, back pain, and handling a treatment regimen and possibly its side effects. For these reasons, the toll the condition takes on one's visual appearance sometimes takes a back seat to more immediate concerns. Nevertheless, finding clothes that fit and are reasonably... Read moreChevron

More Promising Results for Denosumab -- Potential Osteoporosis Medication

Pharmaceutical company Amgen has just released more positive findings for denosumab, a new osteoporosis drug in development. The latest studies indicate that the medication, which would be given as injections twice a year, helped increase bone mass in the lumbar spine significantly over use of a placebo.  The research indicates that it can... Read moreChevron

After an Osteoporosis Hip Fracture: Recovering at the Hospital

Suffering a hip fracture can be the most devastating consequence of osteoporosis. When those crucial bones shatter, it can destroy various aspects of life previously taken for granted - including one's mobility, independence and overall health. In the worst case, the injury may trigger a cascade of negative events and even... Read moreChevron

Treating Osteoporosis with Vitamin D

Even more research is substantiating the positive effects of Vitamin D -- and the negative effects of enough of this crucial vitamin. At the annual meeting of the American Association of Clinical Endocrinologists in May, Dr. Harinder Singh will present data indicating deficiency of Vitamin D to be widespread among... Read moreChevron

Beyond Bisphosphonates - New Osteoporosis Medications Under Research: Denosumab and Protelos

For those dissatisfied with current drug options for treating osteoporosis: a new medication being developed by Amgen may be making headway toward the U.S. market. Denosumab, as it is called, would be taken by injection twice a year. The drug inhibits bone remodeling by binding to and thereby blocking the function of a protein known as... Read moreChevron

  • Font size
  • Bookmark
  • Save
  • Report abuse

Ask a Question

Get answers from our experts and community members.

View all questions (863) >